# Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes

> **NCT05109949** · PHASE3 · UNKNOWN · sponsor: **Centro Universitario de Ciencias de la Salud, Mexico** · enrollment: 72 (actual)

## Conditions studied

- Diabetes Mellitus Type 2 Without Complication

## Interventions

- **DRUG:** Dapagliflozin 10Mg Tab
- **DRUG:** Empagliflozin 25 MG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05109949
- **Lead sponsor:** Centro Universitario de Ciencias de la Salud, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-30
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05109949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05109949, "Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05109949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*